Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice

European Journal of Pharmacology

Volumn 590, Issue 1-3, 2008, Pages 417-422

  Li, Yue ^a   Dong, Ji Bin ^a   Wu, Man Ping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apolipoprotein A I expression; CD14; Cytokine; Lipopolysaccharide; Multiple organ damage; Systemic inflammation

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN A1; BETA ACTIN; CD14 ANTIGEN; CREATINE KINASE; CREATININE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY INJURY; LUNG LAVAGE; MALE; MORPHOLOGY; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD14; APOLIPOPROTEIN A-I; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPIDS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MULTIPLE ORGAN FAILURE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48049092375     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.047     Document Type: Article

References (29)

1. Baue A.E., Durham R., and Faist E. Systemic inflammatory response syndrome, multiple organ dysfunction syndrome, multiple organ failure: are we winning the battle?. Shock 10 (1998) 79-89
2. Belalcazar L.M., Aksam M., Boyd C., Kazuhiro O., Chen K.H., Lucio P., Arthur B., and Lawrence C. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerosis plaques in a mouse model of familial hypercholesterolemia. Circulation 107 (2003) 2726-2732
3. Benoit P., Emmanuel F., Caillaud J.M., Bassinet L., Castro G., Gallix P., Fruchart J.C., Branellec D., Denèfle P., and Duverger N. Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models. Circulation 99 (1999) 105-110
4. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 115 (1991) 457-469
5. Carlson C.A., Steinwaerder D.S., Stecher H., Shayakhmetov D.M., and Lieber A. Rearrangements in adenoviral genomes mediated by inverted repeats. Meth. Enzymol. 346 (2002) 277-292
6. Fry D.E., Pearlstein L., Fulton R.L., and Polk H.C. Multiple system organ failure: the role of uncontrolled infection. Arch. Surg. 115 (1980) 136-140
7. Horn K.D. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS). Q. J. Med. 91 (1998) 265-277
8. Karima R., Matsumoto S., Higashi H., and Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure. Mol. Med. Today 5 (1999) 123-132
9. Kopfler W.P., Willard M., Betz T., Willard J.E., Gerard R.D., and Meidell R.S. Encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation 90 (1994) 1319-1327
10. Liao X.L., Lou B., Ma J., and Wu M.P. Neutrophils activation can be diminished by apolipoprotein A-I. Life Sci. 77 (2005) 325-335
11. Ma J., Liao X.L., Lou B., and Wu M.P. Role of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim. Biophys. Sin. (Shanghai) 36 (2004) 419-424
12. Mammen E.F. The haematological manifestations of sepsis. J. Antimicrob. Chemother. 41 (1998) 17-24 (Suppl. A)
13. Matsuura K., Ishida T., Setognchi M., Higuchi Y., Akizuki S., and Yamamoto S. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J. Exp. Med. 179 (1994) 1671-1676
14. O'Brien J.M., Ali N.A., Aberegg S.K., and Abraham E. Sepsis. Am. J. Med. 120 (2007) 1012-1022
15. Pajkrt D., Doran J.E., Koster F., Lerch P.G., Arnet B., van der Poll T., ten Cate J.W., and van Deventer S.J.H. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 184 (1996) 1601-1608
16. Parillo J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328 (1993) 1471-1477
17. Puranik R., Bao S., Nobecourt E., Nicholls S.J., Dusting G.J., Barter P.J., Celermajer D.S., and Rye K. Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis 196 (2007) 240-247
18. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zahringer U., Seydel U., Padova F.D., Schreier M., and Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8 (1994) 217-225
19. Rubin E.M., Ishida B.Y., Clift S.M., and Krauss R.M. Expression of human Apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 434-438
20. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60 (1996) 8-26
21. Tangirala R.K., Tsukamoto K., Chun S.H., Usher D., Puré E., and Rader D.J. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 100 (1999) 1816-1822
22. Thaveeratitham P., Plengpanich W., Naen-Udorn W., Patumraj S., and Khovidhunkit W. Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro. J. Endotoxin Res. 13 (2007) 58-64
23. Ulevitch R.J. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv. Immunol. 53 (1993) 267-289
24. Van Gorp E.C., Suharti C., Ten Cate H., Dolmans W.M., van der Meer J.W., Ten Cate J.W., and Brandjes D.P. Infectious diseases and coagulation disorders. J. Infect. Dis. 180 (1999) 176-186
25. Wenzel R.P., Pinsky M.R., Ulevitch R.J., and Young L. Current understanding of sepsis. Clin. Infect. Dis. 22 (1996) 407-413
26. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein (see comments). Science 249 (1990) 1431-1433
27. Wright S.D., Ramos R.A., Hermanowski-Vosatska A., Rockwell P., and Detmers P.A. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin dependence of lipopolysaccharide binding protein and CD14. J. Exp. Med. 173 (1991) 1281-1286
28. Wu A.H., Hinds C.J., and Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21 (2004) 210-221
29. Yan Y.J., Li Y., Lou B., and Wu M.P. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice. Life Sci. 79 (2006) 210-215